Pillsbury represented MP Biomedicals Holdings, LLC, in the sale of its wholly-owned subsidiary, Santa Ana-based MP Biomedicals, LLC, and fourteen of its worldwide affiliates to a wholly-owned subsidiary of China state-owned enterprise Valiant Co., Ltd. The closing of the sale of MP Biomedicals, LLC took place on Friday, March 18 with the related sale of MP Biomedicals’ facility in Solon, Ohio, taking place on March 22.

MP Biomedicals manufactures and sells a comprehensive line of life sciences, fine chemical and diagnostics products. Valiant Co. Ltd. develops, manufactures and sells fine chemical products, including liquid crystal materials, pharmaceutical intermediates and photo-electronic chemicals.

Ed Perron, Jason Stirling and David Livdahl led the team representing MP Biomedicals Holdings, supported by Los Angeles associates Karen Chan, Daniel Raisin, Brian Cruz, Tammy Chang and Ron Robertson, Beijing associates Lisa Li and intern Wenjun Cai, Carmel Valley associate Brandt Schmidt and Silicon Valley associate Matt Ryan. Los Angeles partner Bill Waller was responsible for real estate and environmental matters in connection with the sale of the company and its Solon, Ohio, facility. Washington, DC partner Nancy Fischer, supported by partner Jim Glasgow, counsel Chuca Meyer and associates Matt Rabinowitz, Ben Cote and Roland Backhaus, took the lead on regulatory matters. Partners Chris Patay, Dana Newman, Sheryl Stein, Marcus Wu and Mike Rizzo provided advice on corporate, tax, employment, benefits and government contract issues, respectively.